Trial Profile
Phase I trial of a pegylated erythropoietin biosimilar [PEG-EPO] for anaemia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2014
Price :
$35
*
At a glance
- Drugs Recombinant erythropoietin (Primary)
- Indications Anaemia
- Focus Adverse reactions
- 27 Feb 2014 New trial record